Overview
Crinone Vaginal Gel contains 8% natural micronized progesterone in a bioadhesive gel base. It is primarily used for hormone replacement therapy in women with progesterone deficiency, particularly during assisted reproductive technology (ART) cycles like IVF. Administered vaginally, Crinone provides targeted progesterone support to prepare and maintain the uterine lining for embryo implantation and early pregnancy support.





